Loading clinical trials...

RECRUITINGNA

Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary Study

NCT05572424•Centre Hospitalier Universitaire de Besancon

Summary

The Juvenile Idiopathic Arthritis (JIA) affects joints mobility and leads pain, impacting the practice of physical activities. Adapted Physical Activities are rehabilitation methods increasingly used, but additional studies are needed to define the nature of the physical activity for patients with JIA. The ATHLETIQUE project aims to evaluate the impact of a program integrating APA sessions together with the wearing of a pedometer watch on disease activity of patients with JIA.

Eligibility

Age

6 - 17 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Children (boys and girls) aged 6 to 17 years
•Children with juvenile idiopathic arthritis (JIA) : oligoarticular, polyarticular, psoriatic or enthesitis-related arthritis, with more than one year of disease progression
•Children on stable conventional or biotherapy 3 months prior to inclusion
•Children with a computer/tablet/connected phone that allows them to follow adapted physical activities sessions online
•If sexually active adolescents, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double barrier method, contraceptive patches)
•Signed informed consent to participate indicating that the parent(s) understand the purpose and procedures required for the study and agree(s) that their child(ren) will participate in the study and abide by the requirements and restrictions of the study
•Affiliation with a French social security system or beneficiary of such a system.
•Treatment by intra-articular infiltration less than 1 month old (immobilization required after the procedure and temporary cessation of physical activity unavoidable)
•Contraindications to physical activity
•Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
+3 more criteria

Exclusion Criteria

•Intra-articular infiltration treatment during the 3 months of the adapted physical activity (APA) program (except for the temporomandibular joint)
•Change of biotherapy during the 3 months of the APA program if the treatment is ineffective
•Physical inability to engage in physical activity, unrelated to JIA, during the 3-month of the APA program

Locations (3)

CHU de Besançon

Besançon, France

Hospices Civils de Lyon

Lyon, France

Hôpital Nord Franche-Comté

Trévenans, France

Key Dates

Start Date

July 5, 2023

Primary Completion Date

September 1, 2024

Completion Date

October 1, 2024

Last Updated

March 18, 2024

Enrollment

ESTIMATED participants

Conditions

Juvenile Idiopathic Arthritis

Interventions

Adaptated Physical Activity (APA) + pedometer watch

OTHER

Contacts

Claire BALLOT-SCHMIT, MD

CONTACT

0381219139 cballotschmit@chu-besancon.fr

Stéphanie PY, PhD

CONTACT

0381218993 s1py@chu-besancon.fr

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA

NCT06870045

Juvenile Idiopathic ArthritisChildhood Rheumatic Disease

View study

RECRUITING

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT04902807

Autoimmune Lymphoproliferative SyndromeAutoimmune Cytopenia+18 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 18, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary Study

Inclusion Criteria

Exclusion Criteria

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis